PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Leung KB et al. Some further properties of human pulmonary mast cells recovered by bronchoalveolar lavage and enzymic dispersion of lung tissue. 1987 Agents Actions pmid:2440274
Church MK et al. Non-IgE-dependent bacteria-induced histamine release from human lung and tonsillar mast cells. 1987 Clin. Allergy pmid:2441900
Rodriguez R et al. Effect of nimodipine on arachidonic acid metabolites after subarachnoid hemorrhage. 1987 Acta Neurol. Scand. pmid:3120489
Haxhiu MA et al. [Bronchial response to prostaglandins (F2 alpha and D2) and leukotrienes in patients with bronchial asthma]. 1986 Jan-Mar Plucne Bolesti pmid:3466189
Frölich JC et al. Advances in the analysis of eicosanoids by ELISA and GC/MS/MS. 1986 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2949561
Schleimer RP et al. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. 1986 J. Immunol. pmid:3082976
Barnea A et al. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants. 1986 Endocrinology pmid:3525128
Nordlund JJ et al. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. 1986 J. Invest. Dermatol. pmid:3528310
Hattori Y and Levi R Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. 1986 J. Pharmacol. Exp. Ther. pmid:3012066
Tsao CJ et al. In-vitro effects of antineoplastic prostaglandins on human leukemic cell growth and normal myelopoiesis. 1986 Leuk. Res. pmid:3012210
Halenda SP et al. Effects of thrombin, phorbol myristate acetate and prostaglandin D2 on 40-41 kDa protein that is ADP ribosylated by pertussis toxin in platelets. 1986 FEBS Lett. pmid:3015684
Hickok NJ et al. Characterization of prostaglandin endoperoxide synthase from a human cell line. 1986 Biochim. Biophys. Acta pmid:3087430
Todo S et al. Cell kinetic studies of PGD2 cytotoxicity on the in vitro growth of human neuroblastoma. 1986 Prostaglandins Leukot Med pmid:3016753
Bhattacharya SK The antinociceptive effect of intracerebroventricularly administered prostaglandin D2 in the rat. 1986 Psychopharmacology (Berl.) pmid:3016786
Hamid-Bloomfield S and Whittle BJ Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets. 1986 Br. J. Pharmacol. pmid:3017497
Shalit M et al. New role for heparan sulfate: regulator of leukotriene generation in mouse E-mast cells. 1986 Life Sci. pmid:3018403
Ohno K et al. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition. 1986 Biochem. Biophys. Res. Commun. pmid:3464277
Peters SP et al. Mediator release from human lung under conditions of reduced oxygen tension. 1986 J. Pharmacol. Exp. Ther. pmid:2425080
Wells E et al. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins. 1986 J. Immunol. pmid:2431048
MacDermot J Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo. 1986 Biochem. Pharmacol. pmid:2427086
Heavey DJ et al. Prostaglandin D2 and histamine release in cold urticaria. 1986 J. Allergy Clin. Immunol. pmid:2428856
Suzuki H et al. [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. 1986 Nihon Naibunpi Gakkai Zasshi pmid:3465609
Eady RP The pharmacology of nedocromil sodium. 1986 Eur J Respir Dis Suppl pmid:2429854
Kleeberger SR et al. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. 1986 J. Appl. Physiol. pmid:2430928
Wells E et al. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. 1986 J. Immunol. pmid:2431049
Ashby B Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. 1986 J Cyclic Nucleotide Protein Phosphor Res pmid:2432105
Koro O et al. Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. 1986 Br. J. Dermatol. pmid:2432916
Narumiya S and Fukushima M Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. 1986 J. Pharmacol. Exp. Ther. pmid:3772804
Narumiya S et al. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. 1986 J. Pharmacol. Exp. Ther. pmid:3772805
Bregman MD et al. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. 1986 Cancer Res. pmid:3698005
Keeting PE et al. Rat lens prostaglandin biosynthesis during galactose-induced cataractogenesis. 1986 Exp. Eye Res. pmid:3028846
Schleimer RP et al. Characterization of inflammatory mediator release from purified human lung mast cells. 1986 Am. Rev. Respir. Dis. pmid:3485946
Peters SP et al. The pharmacologic control of mediator release from human basophils and mast cells. 1986 Respiration pmid:3494282
Bhuyan BK et al. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. 1986 Cancer Res. pmid:3456266
Brooks DP et al. Role of brain prostaglandins in the control of vasopressin secretion in the conscious rat. 1986 Endocrinology pmid:3456303
Watanabe K et al. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3456602
Maclouf J et al. Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2. 1986 Prostaglandins pmid:3456623
Barnes VF and Heavey DJ Effect of prostaglandin D2 on histamine-induced weals in human skin. 1986 Br. J. Pharmacol. pmid:3456816
Gaetani P et al. Prostaglandin D2 monitoring in human CSF after subarachnoid hemorrhage: the possible role of prostaglandin D2 in the genesis of cerebral vasospasm. 1986 Ital J Neurol Sci pmid:3456998
Sugiyama T et al. Platelet prostaglandin D2 dehydrogenase in patients with myeloproliferative disorders. 1986 Prostaglandins Leukot Med pmid:3457389
Kikuchi Y et al. Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. 1986 Cancer Res. pmid:3458525
Ruzicka T et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. 1986 J. Invest. Dermatol. pmid:3018086
Kuno S et al. Prostaglandin E2 administered via anus causes immunosuppression in male but not female rats: a possible pathogenesis of acquired immune deficiency syndrome in homosexual males. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3458226
Rees MC and Kelly RW Prostaglandin D2 release by endometrium and myometrium. 1986 Br J Obstet Gynaecol pmid:3466645
Hardy CC et al. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. 1986 Br. J. Pharmacol. pmid:3467804
Inoué S Multifactorial humoral regulation of sleep. 1986 Clin Neuropharmacol pmid:3471328
Bhuyan BK et al. Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture. 1986 Invest New Drugs pmid:3473056
Watanabe Y et al. Modulation by prostaglandin D2 of mitral cell responses to odor stimulation in rabbit olfactory bulb. 1986 Brain Res. pmid:2873871
Hiroshima O et al. Basal level of prostaglandin D2 in rat brain by a solid-phase enzyme immunoassay. 1986 Prostaglandins pmid:3532208
Strobl-Jäger E et al. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life. 1986 Prostaglandins Leukot Med pmid:3540998